Clinical Trials on Advance Illness Patients With OIC in India

Total 5 results

Postgraduate Institute of Medical Education and...

Completed

A Randomized Trial of 4% Nebulized Lignocaine vs. 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy

Patients With Indication for Flexible Bronchoscopy

India
Tata Memorial Hospital

Completed

3D Ultra Sound for Resection of Brain Tumors (SonoRCT)

Patients With Resectable Brain Tumors

India
Jyoti Clinical and Pathological Laboratory

Completed

Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs

Antihyperglycemic Effect in Type 2 Diabetic Patients With Secondary Failure to Oral Hypoglycemic Agents

India
AstraZeneca

Completed

FAsenra Safety Trial in India (FAST)

In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India

India
Novartis Pharmaceuticals

Recruiting

Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation

Italy, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom

3

Subscribe